# OnCo record ticaros (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/ticaros/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "ticaros" ;
  schema:name "TICAROS"@en ;
  schema:alternateName "TiCARos"@en ;
  schema:description "TICAROS is a Korean company making CAR-T cell therapy, in which a patient's own immune cells are engineered to recognise and kill cancer cells. Its first product, TC011, targets CD19 and is being tested in B-cell lymphomas that have come back or stopped responding."@en ;
  schema:url <https://onco.cc/companies/ticaros/>, <https://www.ticaros.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.ticaros.com/>, <https://clinicaltrials.gov/study/NCT07360288> ;
  schema:addressCountry "KR" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/follicular-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/> ;
  onco:trials <https://onco.cc/trials/nct07473167/> .